GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/24/2026 4:07:50 PM | View | Proxy | SEC | Y 2025 | ||||||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/17/2026 7:19:33 AM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $29,089,000 | EPS -$11.25 | Export Earnings Model | ||
| Adial Pharmaceuticals, Inc. (ADIL) | 8/17/2026 7:00:40 AM | View | Financials | Earnings | WIRE | 2Q 2026 | Assets $29,089,000 | EPS -$11.25 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/15/2026 4:04:21 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $29,089,000 | EPS -$11.25 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 5/11/2026 8:41:57 AM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $5,227,321 | EPS -$1.48 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 5/8/2026 4:35:12 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $5,227,321 | EPS -$1.48 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 3/6/2026 8:16:25 AM | View | Financials | Earnings | SEC | Y 2025 | Assets $6,673,367 | EPS -$11.48 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 3/5/2026 5:11:56 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $6,673,367 | EPS -$11.93 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 1/6/2026 4:17:15 PM | View | Proxy | SEC | Y 2025 | ||||||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 11/14/2025 8:36:38 AM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $5,659,847 | EPS -$0.08 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 11/13/2025 4:14:00 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $5,659,847 | EPS -$0.08 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/14/2025 8:36:41 AM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $6,801,703 | EPS -$0.18 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/13/2025 4:24:45 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $6,801,703 | EPS -$0.18 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 6/27/2025 4:07:46 PM | View | Proxy | SEC | Y 2024 | ||||||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 6/10/2025 5:29:58 PM | View | Proxy | SEC | Y 2024 | ||||||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 5/15/2025 8:36:28 AM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $3,451,122 | EPS -$0.34 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 5/14/2025 4:12:44 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $3,451,122 | EPS -$0.34 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 3/4/2025 9:03:26 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $5,043,942 | EPS -$2.72 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 3/4/2025 8:59:01 AM | View | Financials | Earnings | SEC | Y 2024 | Assets $5,043,942 | EPS -$0.15 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 11/13/2024 4:53:38 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $6,712,719 | EPS -$0.38 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 9/27/2024 5:22:18 PM | View | Proxy | SEC | Y 2023 | ||||||
| Adial Pharmaceuticals, Inc. (ADIL) | 8/14/2024 8:31:39 AM | View | Financials | Earnings | WIRE | 2Q 2024 | Assets $4,948,703 | EPS -$0.59 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/13/2024 4:29:35 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $4,948,703 | EPS -$0.59 | ||
| Adial Pharmaceuticals, Inc. (ADIL) | 5/15/2024 8:31:54 AM | View | Financials | Earnings | WIRE | 1Q 2024 | Assets $6,684,381 | EPS -$2.19 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 5/14/2024 5:18:57 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $6,684,381 | EPS -$2.19 | ||
| Adial Pharmaceuticals, Inc. (ADIL) | 4/2/2024 8:32:12 AM | View | Financials | Earnings | WIRE | 1Q 2024 | Assets $6,684,381 | EPS -$2.19 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 4/1/2024 4:20:44 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $4,736,605 | EPS -$3.60 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 12/8/2023 11:09:28 AM | View | Proxy | SEC | Y 2022 | ||||||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 11/14/2023 7:45:24 PM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $2,867,437 | EPS -$1.18 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 11/14/2023 6:46:39 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $2,867,437 | EPS -$1.18 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 10/30/2023 5:38:22 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2023 ending: 6/30/2023 | Assets $3,778,943 | EPS $0.96 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 10/2/2023 6:07:59 AM | View | Proxy | SEC | Y 2022 | ||||||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/21/2023 8:47:28 AM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $3,778,943 | EPS $0.96 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/21/2023 8:37:43 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $3,778,943 | EPS $0.96 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 5/12/2023 4:16:53 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $3,901,678 | EPS -$0.11 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 5/12/2023 4:12:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $3,901,678 | EPS -$0.11 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 3/31/2023 6:16:26 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $5,732,804 | EPS -$0.11 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 3/30/2023 5:07:41 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $5,732,804 | EPS -$0.51 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 3/6/2023 5:31:19 PM | View | Proxy | SEC | Y 2022 | ||||||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 11/15/2022 7:10:10 AM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $7,741,684 | EPS -$0.12 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 11/14/2022 8:48:10 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $7,741,684 | EPS -$0.12 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 9/1/2022 5:17:00 PM | View | Proxy | SEC | Y 2021 | ||||||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/16/2022 12:28:18 PM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $10,923,297 | EPS -$0.16 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/15/2022 6:38:59 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $10,923,297 | EPS -$0.16 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 5/16/2022 9:25:52 AM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $13,963,648 | Export Earnings Model | |||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 5/16/2022 6:20:58 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $13,963,648 | |||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 3/28/2022 4:56:30 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $7,474,975 | EPS -$1.04 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 11/15/2021 6:44:16 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $10,446,206 | EPS -$0.22 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/27/2021 6:05:04 AM | View | Proxy | SEC | Y 2020 | ||||||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/23/2021 6:09:42 AM | View | Proxy | SEC | Y 2020 | ||||||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/12/2021 5:21:27 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $8,062,915 | EPS -$0.25 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 5/17/2021 5:43:36 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $8,625,499 | |||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 3/22/2021 5:12:06 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $5,491,444 | EPS -$0.87 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 11/13/2020 4:26:16 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $8,178,139 | EPS -$0.24 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/13/2020 5:04:03 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $9,474,858 | EPS -$0.16 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 7/21/2020 6:02:46 AM | View | Proxy | SEC | Y 2019 | ||||||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 5/14/2020 5:26:29 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $5,941,236 | EPS -$0.22 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 3/20/2020 5:35:41 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $7,679,637 | EPS -$0.87 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 11/14/2019 7:31:29 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $9,506,926 | EPS -$0.17 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 8/13/2019 6:15:29 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $10,687,369 | EPS -$0.21 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 7/8/2019 4:08:11 PM | View | Proxy | SEC | Y 2018 | ||||||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 5/13/2019 5:17:52 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $12,059,929 | EPS -$0.33 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 2/19/2019 9:42:22 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $4,699,285 | EPS -$2.44 | ||
| Adial Pharmaceuticals, Inc. (ADIL) | 11/14/2018 8:02:09 AM | View | Financials | Earnings | WIRE | 3Q 2018 | Assets $5,252,174 | EPS -$1.48 | Export Earnings Model | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 11/14/2018 6:09:53 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $5,252,174 | EPS -$1.48 | ||
| ADIAL PHARMACEUTICALS, INC. (ADIL) | 9/10/2018 6:17:05 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $187,087 | EPS -$0.50 |